Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly harm » significantly vary (Expand Search), significantly high (Expand Search), significantly larger (Expand Search)
significantly i » significantly _ (Expand Search), significantly high (Expand Search), significantly less (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly harm » significantly vary (Expand Search), significantly high (Expand Search), significantly larger (Expand Search)
significantly i » significantly _ (Expand Search), significantly high (Expand Search), significantly less (Expand Search)
-
181
-
182
-
183
-
184
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…The values are expressed as the means ± SDs and were analyzed according to the variance of the factorial design. **, *** and ****denote <i>p</i> < 0.01, < 0.001 and < 0.0001, respectively; ns = not significant.…”
-
185
RipU<sup>K60</sup> decreases microtubule abundance at 48 hours post infiltration.
Published 2024“…(B) Heterologous expression of RipU<sup>K60</sup> significantly decreased microtubule number compared to controls at 48 hpi in <i>N</i>. …”
-
186
Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae
Published 2025“…We have developed the Multiplex Integrated RPA-CRISPR/Cas12a detection Assay (MIRCA) for simultaneous detection of Neisseria gonorrheae (<i>Ng</i>) and mutations with decreased susceptibility to cephalosporins. …”
-
187
-
188
-
189
-
190
HDECO: A method for Decreasing energy and cost by using virtual machine migration by considering hybrid parameters
Published 2025“…</p><p dir="ltr">Compared to the ECIB algorithm and previous approaches, HDECO achieved significant improvements:</p><ul><li><b>Up to 10% reduction in energy consumption</b></li><li><b>8% decrease in overall execution cost</b></li><li><b>Better real execution time and fewer unnecessary migrations</b></li></ul><p dir="ltr">This makes HDECO an effective and lightweight solution for instance-intensive cloud workflows.…”
-
191
-
192
-
193
-
194
<b>The loss of insulin-positive cell clusters precedes the decrease of islet frequency and beta cell area in type 1 diabetes</b>
Published 2025“…Moreover, changes in endocrine composition also occurred in mAAb+ donors, including a significant decrease in the INS+ islet fraction. These data suggest preferential loss of INS+ small endocrine objects early in type 1 diabetes development.…”
-
195
-
196
Presentation 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.pptx
Published 2025“…</p>Results<p>Meta-analysis confirmed significantly reduced circulating BDNF in CKD patients (WMD = −0.62 ng/mL, 95% CI [-0.98, −0.25], P < 0.001; I<sup>2</sup> = 87%). …”
-
197
-
198
-
199
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
-
200
Presentation 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.pdf
Published 2025“…Compared to the control group, the prehospital TXA group exhibited a significant reduction in 24-h mortality with an OR of 0.72 and a 95% CI of 0.54–0.94 (p = 0.02), while no statistically significant difference in the incidence of venous thromboembolism (VTE; OR: 1.14, 95% CI: 0.98–1.33, p = 0.09). …”